Investigating Dynamic Interactions in Distributed Cognitive Control Networks
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jun 28, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how the brain works during tasks that require thinking, remembering, and reasoning, especially in people with cognitive impairments like dementia, attention deficit disorder (ADD), and depression. By studying brain activity, the researchers hope to learn more about these conditions and find better treatments. Participants will have their brain activity recorded while they perform specific tasks, which will help scientists see how different parts of the brain interact. It’s important to know that these recordings are in addition to standard procedures done to monitor for seizures and won’t change the usual care participants receive.
To be eligible for the trial, participants must be at least 18 years old and diagnosed with epilepsy that has not responded to other treatments. They should also be eligible for surgery based on a team of specialists' review. Those who cannot provide informed consent or have major health issues may not qualify. If you join the study, you can expect to play a role in advancing our understanding of brain functions and possibly helping others with similar conditions in the future. Your participation could contribute to important discoveries in treating cognitive impairments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible for surgery based on multi-disciplinary consensus review
- • Have a diagnosis of medically-refractory epilepsy
- • A minimum of 18 years of age
- • Willingness to participate in the paradigms described in the protocol
- Exclusion Criteria:
- • Inability to provide full and informed consent
- • Age younger than 18
- • Are not physically able to participate in study-related activities
- • Major medical or surgical complication
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Trial Officials
Jessica N Bentley, MD
Principal Investigator
The University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported